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BCLAF1 is a radiation-induced H2AX-interacting
partner involved in cH2AX-mediated regulation of
apoptosis and DNA repair
YY Lee1, YB Yu1,3,4, HP Gunawardena1,3, L Xie1 and X Chen*,1,2,3,4
H2AX, a histone H2A variant, has a key role in the cellular response to DNA double-strand breaks (DSBs). H2AX senses DSBs
through rapid serine 139 phosphorylation, concurrently leading to the formation of phospho-(c)H2AX foci with various proteins.
However, in the cells with different sensitivity to ionizing radiation (IR)-induced DSBs, still incomplete are those specific proteins
selectively recruited by cH2AX to decide different cell fates. Because the abundance of cH2AX indicates the extent of DSBs, we
first identified IR-induced dose-dependent H2AX-interacting partners and found that Bcl-2-associated transcription factor 1
(BCLAF1/Btf) showed enhanced association with cH2AX only under high-dose radiation. In acutely irradiated cells, BCLAF1
promoted apoptosis of irreparable cells through disturbing p21-mediated inhibition of Caspase/cyclin E-dependent,
mitochondrial-mediated pathways. Meanwhile, BCLAF1 co-localized with cH2AX foci in nuclei and stabilized the Ku70/DNA-
PKcs complex therein, facilitating non-homologous end joining (NHEJ)-based DSB repair in surviving cells. In tumor cells,
BCLAF1 was intrinsically suppressed, leading to formation of anti-apoptotic Ku70–Bax complexes and disruption of Ku70/DNA-
PKcs complexes, all of which contribute to tumor-associated apoptotic resistance and cell survival with defective NHEJ DNA
repair. For the first time, our studies reveal that, based on the extent of DNA damage, BCLAF1 is involved in the cH2AX-mediated
regulation of apoptosis and DNA repair, and is a cH2AX-interacting tumor suppressor.
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Based on the severity of DNA damage, cells activate specific
pathways for cell fate decisions. While an acute ionizing
radiation (IR) triggers pro-apoptotic signals in cells with
irreparable DNA damage,1 cells persistently exposed to
radiation can become resistant/adapted to double-strand
breaks (DSBs),2 which are with an increased risk of
carcinogenesis. However, the pathways/mechanisms that
determine defined cell fate remain to be elucidated.
The replacement histone H2AX senses DSBs with rapid
phosphorylation of serine 139 (gH2AX), which recruits various
proteins associated with DNA damage/repair, cell cycle check
points,3 and so on, to form gH2AX foci indicative of DSB-
associated genome instability4 and premalignant lesions.3 By
using our quantitative proteomics approach,5,6 we have
identified novel H2AX-associating proteins, revealing new
aspects of H2AX in regulating IR-induced cell cycle arrest7
and nucleosome dynamics.8 Together with recent findings
that changes in H2AX site-specific phosphorylation9 can
selectively modulate cellular apoptosis or survival,10 we
reasoned that H2AX coordinates a post-DSB ‘switching’
program that chooses specific cell fate-determining pathways
by selectively recruiting particular proteins in the cells
differentially irradiated with acute versus prolonged IR.
By multiplex quantitative proteomics,7 we first examined how
different H2AX-coordinated complexes are formed in cells
exposed to different IR doses. We found the most notable
hierarchical clusters of high-dose IR-induced gH2AX interactors
were those associated with p53 regulation, apoptosis, or both,
among which was BCLAF1, previously implicated in TP53-
mediated DDR/apoptosis,11 and lung development.12 We then
explored the novel function of BCLAF1 in the gH2AX-coordinated
cell fate-determining pathways under different radiation condi-
tions including those diverse phenotypes associated with either
induction of apoptosis in irreparable cells, or cell survival with
active DNA repair, or cell survival toward carcinogenesis. From a
systemic viewpoint, for the first time, we have elucidated a
mechanistic link between the gH2AX-mediated interaction net-
work and different cell fate-determining pathways that drive cells
toward either survival or carcinogenesis following exposure to
acute or prolonged IR. Specifically, we revealed how dysregu-
lated BCLAF1 under radio-resistant conditions is associated with
an impaired apoptotic feedback loop and ineffective DNA repair.
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Results
High-dose IR triggers the recruitment of various proteins
associated with apoptosis and p53 regulation to gH2AX
foci. Using our AACT-based quantitative proteomic
approach7 (Figure 1a), we unambiguously identified multiple
IR-induced dose-dependent gH2AX-associating proteins
(Supplementary Tables S1 and S2 and Supplementary
Figure S1). We then performed a domain-based analysis to
construct a two-dimensional hierarchical clustering map,
wherein many IR-inducible gH2AX-associating proteins
grouped either structurally or functionally, further confirming
the accuracy of our proteomics data (Supplementary Tables
S2 and S3 and Supplementary Figure S2). Meanwhile, the
data-dependent network analysis13 of the gH2AX interac-
tome revealed connectivity among multiple proteins known to
be associated with either regulation of p53,14 cell cycle, or
apoptosis15 (Supplementary Figure S3 and Supplementary
Table S2), suggesting that all of the pathways represented by
these gH2AX-docking proteins are interconnected. It caught
our special attention that among them, a pro-apoptotic
p53 regulator, BCLAF1,16 previously unknown to interact
with H2AX, exhibited enhanced association with H2AX
specifically in high-dose-irradiated cells (Figure 1b). Further,
more BCLAF1 was detected in the gH2AX immunoprecipitate
pulled down from 10-Gy-irradiated cells compared
with those in low-dose or non-irradiated cells, which is
consistent with the high-dose-induced increase of gH2AX
population in the ‘reverse-order’ immunoprecipitate pulled
down by using anti-BCLAF1 antibody (Figure 1c), indicating
that BCLAF1 directly binds gH2AX in a high-dose IR-
inducible manner.
High-dose IR triggers the translocation of BCLAF1
to cH2AX foci and an enhanced binding of BCLAF1 to
CPE-TP53. Since an apoptotic signal can induce binding of
BCLAF1 to a nuclear membrane protein, Emerin,17 we used
immunofluorescence to determine where this high-dose-
dependent BCLAF1–gH2AX association occurs in situ. In
non-irradiated cells, BCLAF1 was distributed widely in the
nucleoplasm, clearly separated from the background gH2AX
foci. In response to low-dose radiation, few BCLAF1 foci
were induced close to the nuclei where gH2AX foci were also
located. In the 10-Gy-irradiated pro-apoptotic cells showing
significant chromatin condensation (Figure 1d), more
BCLAF1 were co-localized with gH2AX foci close to the
nuclear periphery where heterochromatin is located for
coordinating either transcriptional regulation or maintenance
of chromosome integrity.18
We next determined whether BCLAF1 is indeed involved in
the gH2AX-mediated DSB damage recognition and repair.
First, few BCLAF1 and 53BP1 were found co-localized in the
10-Gy-irradiated cells showing a significant chromatin con-
densation (Figure 1d), indicating that the dose-dependent
translocation of BCLAF1 is highly sensitive to the extent of
DSBs and is directly involved in gH2AX-mediated DNA
damage response (DDR). Further, in chromatin immunopre-
cipitation analysis, binding of both BCLAF1 and gH2AX to
CPE-TP53 was induced substantially in the 10-Gy-irradiated
cells compared with non-treated cells (Figure 2a). Given
BCLAF1 was previously known to positively regulate p53
expression by interacting CPE-TP53 during DNA damage,11
these observations indicated that gH2AX in the nucleosome,
accumulated at DNA damage sites, serves as the scaffold to
temporarily assist BCLAF1, a pro-apoptotic transcriptional
factor, to get access to CPE-TP53, leading to upregulated p53
mRNA and protein levels in the 10-Gy-irradiated cells
(Figure 2b).
BCLAF1 is involved in p21-dependent cell cycle regula-
tion. p53 is essential in diverse DDR pathways associated
with either cell cycle arrest, DNA lesion repair, or induction of
apoptosis in cells containing irreparable DNA damage.14
Specifically, in cell cycle arrest at G1 phase, p53 enhances
transcription of p21(cip1/waf1), which in turn inhibits cdk
activity.14 Given the involvement of H2AX in the p53/p21
pathway19 and the gH2AX-dependence of BCLAF1, we
therefore explored the role of BCLAF1 in p53/p21-dependent
cell cycle regulation by first examining the effect of BCLAF1
knockdown on expression of p53 and p21. As p53 expres-
sion is affected by SV40 large T-antigen present in the 293 T
cells in which BCLAF1–H2AX interaction was first identified
by proteomics (Figure 1b), we also studied the effect of short-
interfering RNA (siRNA)-mediated knockdown of endogen-
ous BCLAF1 in other cell lines of normal human fibroblasts
(MRC-5 and WI-38), and human osteosarcoma (U2OS),
respectively. As shown in Figure 2c, knocking down BCLAF1
slightly attenuated p53 expression in non-irradiated cells and
had little effect on the 10-Gy IR-induced p53, but generally
led to significant increases in p21 expression in these cell
lines, suggesting that BCLAF1 is involved in p21 regulation.
We therefore tested whether BCLAF1 is required for p21-
induced cell cycle arrest. In asynchronously growing MRC-5
cells highlighted by the phase-characteristic staining (Figures
2d and e), a pronounced G1 phase accumulation was found,
especially in the 10-Gy-irradiated cells with siRNA-mediated
BCLAF1 knockdown, while without siRNA treatment the
population of G2/M phase cells decreased from 25% to 10%
Figure 1 Proteomic identification of IR-induced dose-dependent gH2AX-interacting partners including BCLAF1. (a) Workflow of AACT-based multiplex dual-tagging




containing medium were subjected to IR at the dose level of 0, 7.5 cGy, and 10 Gy, respectively. The immunoprecipitates (IP) originated from each of the three cell pools were
mixed at 1 : 1 : 1 ratio based on the amount of FLAG-tagged H2AX in each IP elute as measured by immunoblotting (IB) prior to mixing. The equally combined IP elutes were
then separated by SDS-PAGE, digested with trypsin, and analyzed by nanoLC-MS/MS. (b) MS spectra of AACT-containing peptides of the representative proteins detected in
the IP mixture. Peptide sequences include IDISPSTLR (BCLAF1), SILQER (Ku86), SDSFENPVLQQHFR (Ku70), LLEEALLR (DNA-PKcs). The relative abundance of the bait
protein, H2AX, in each immunoprecipitate, was measured based on the ratio of isotope peak intensity, and the ratio was calibrated to 1 : 1 : 1 for the normalization of those of
other H2AX-interacting proteins. (c) Immunoblot analysis of the immunoprecipitates pulled down from non-irradiated or 7.5-cGy- or 10-Gy-irradiated cells by anti-gH2AX
antibody. A mouse IgG was used as the control. (d) Immunofluorescence analysis of IR dose-dependent BCLAF1-gH2AX association in situ. The 293T cells were irradiated at
indicated dose level and were then incubated for 1 h prior to fixing and staining with indicated antibodies (lower panel) with both anti-mouse and -rabbit IgG antibodies as the
control. 4,6-diamidino-2-phenylindole (DAPI) was used for DNA staining (top panel). The scale bar is 24 mm
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(Figure 2f). Together with the result (Figure 2c), the suppres-
sion of BCLAF1 promotes both a p21 upregulation and a p21-
dependent growth arrest in G1.
In a p21-dependent manner, cyclin D1 and E are known as
the essential components for regulating the cell cycle at either
early G1 or for late G1-to-S transition.
20 Because BCLAF1 was
Figure 2 BCLAF1 is involved in the gH2AX-mediated regulation of p53/p21 expression and cell cycle progression. (a) Chromatin immunoprecipitation (ChIP) experiments
were performed on non- or 10-Gy-irradiated cells by using anti-BCLAF1 or anti-gH2AX antibody, respectively. The amount of CPE-TP53 bound to either BCLAF1 or gH2AX in
the immunoprecipitate was assayed by RT-PCR using the primers as previously described11 with IgG and input as the quantitative controls. (b) Total RNA was extracted from
non- or 10-Gy-irradiated cells and analyzed by RT-PCR using the primers specific for each of p53 and b-actin. The cell lysates were also immunoblotted (IB) against p53
antibody with GAPDH as the control. (c) The expressions levels of p53 and p21 were compared in four different cell lines including 293T, WI-38, U-2 OS, and MRC-5 without or
with siRNA-mediated BCLAF1 knockdown. Immunoblotting experiments were performed with the indicated antibodies with b-actin as the loading control. (d) Immunostaining
analysis of different phases of cell cycle of MRC-5 cells. BrdU (green) labels S-phase cells while the staining in red for serine 10 phosphorylation at histone H3 (H3S10ph)
highlights the cells at G2/M phase. The cells at either G1- or G2/M-phase were distinguished by either no staining or relatively intense staining, respectively. The co-staining
cells were at S/G2 or late S phase while M-phase cells were identified by their unique chromosomal shape following DAPI staining for DNA (blue). Different cell cycle phases
are indicated in light blue. The scale bars represent 10 mm. (e) Distribution of cell cycle phases highlighted by BrdU and Histone H3S10ph staining. (f) BCLAF1 effect on IR-
induced cell cycle progression. The percentages of MRC-5 cells without or with 10 Gy IR at each different cell cycle stage, G1, S, S/G2, and G2/M, were measured by BrdU and
H3S10ph staining and compared with those in the cells with siRNA-mediated BCLAF1 knockdown (BCLAF1 si). One experiment containing a technical duplicate
representative of two is shown with the data precision indicated by the error bar based on mean±S.D. of duplicate samples. **Po0.05. (g) Effect of BCLAF1 knockdown on
the expression of cyclin D1 and cyclin E. MRC-5 cells were transfected with BCLAF1 siRNA for 2 days prior to immunoblot analysis of the cyclins with indicated antibodies at
1 h after the radiation. b-actin was used as the loading control (upper panel). The intensity of each gel band was determined by ImageJ software. One experiment containing a
technical duplicate representative of two is shown with the data precision indicated by the error bar based on mean±S.D. of duplicate samples. **Po0.05, *Po0.01
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found in a complex that regulates cyclin D1 mRNA stability,21
we tested if BCLAF1 could regulate the p21-dependent cyclin
D1 and E. In the 10-Gy-irradatied cells, cyclin D1 was
downregulated, while cyclin E was upregulated. siRNA-
mediated BCLAF1 knockdown then suppressed more cyclin
D1 than that of cyclin E in cells with or without IR (Figure 2g),
indicating that BCLAF1 affects cell cycle progression by
regulating the p21-dependent cyclins in early G1, which is
often dysregulated in human cancers.22
BCLAF1 is suppressed in radio-resistant cells, and
BCLAF1 differentially regulates cyclin E-mediated cell
cycle progression in differentlly irradiated cells. Further,
we clarified how BCLAF1 regulates diverse DDR to different
extents of DNA damage in either non-irradiated cells, or IR-
responsive cells irradiated by a high-dose radiation at 10 Gy,
and IR-adapted/-resistant cells, which were first primed with
7.5 cGy for 24 h before a second high-dose radiation at 10 Gy
(Figure 3a). These cells under each radiation condition were
collected at a single time point with 1 h post irradiation
recovery. We observed that the 10-Gy IR-responsive cells
displayed a higher propensity for apoptosis indicated by
intense DNA fragmentation, whereas the IR-adapted cells
were radio-resistant/pro-survival and characterized by sig-
nificantly reduced DNA fragmentation (Figure 3a). Because
BCLAF1 was found linking to either pulmonary smooth
muscle development23 or tumor suppression,12 both wild-
type p53 human adenocarcinoma A549 cells16 and p53-
deficient lung carcinoma H1299 cells24 were chosen.
Compared with its expression in IR-responsive A549 cells,
BCLAF1 was found to be intrinsically suppressed under IR-
resistant condition with simultaneously induced p53 and p21
Figure 3 BCLAF1 differentially regulates p21-mediated G1 arrest and apoptotic activity in differentially irradiated cells. (a) Schematic design for generating either ‘IR-
responsive or pro-apoptotic’ or ‘IR-resistant/-adapted or pro-survival’ cells from their exposure to a high-dose (10 Gy) radiation either without or with a 24-h priming IR at low
dose (7.5 cGy), respectively. (b) Immunoblot analysis of the effect of BCLAF1 knockdown by siRNA on expression of p53, p21, and cyclin E in differentially irradiated A549 and
H1299 cells. b-actin was used as the loading control. (c) Effect of BCLAF1 on the cell cycle progression of differentially irradiated cells. The percentages of different cell cycle
phases including G1, S, S/G2 and G2/M were compared for non-irradiated, IR-responsive, and IR-resistant A549 cells without or with siRNA-mediated BCLAF1 knockdown
(BCLAF1 si). One experiment containing a technical duplicate representative of two is shown with the data precision indicated by the error bar based on mean±S.D. of
duplicate samples. **Po0.05, *Po0.01. (d) Effect of BCLAF1 knockdown on the growth and morphology of differentially irradiated A549 cells. DAPI was used to stain DNA.
The scale bar is 48mm. (e) Effect of BCLAF1 knockdown on p21 association with caspase 8 and procaspase-3. Immunoblotting analysis was conducted on the p21
immunoprecipitates from each set of the differentially irradiated A549 cells without or with siRNA-mediated BCLAF1 knockdown (upper panel). Also the levels of Caspase-9,
Caspase-3, and cleaved PARP-1 in whole cell lysates of these untreated or treated cells were analyzed by immunoblotting with indicated antibodies. b-actin was used as the
loading control (bottom panel). Relative intensities representing the binding strength between p21 and either Caspase 8 or Procaspase 3 as well as the expression of Bax,
activated Caspase-9, activated Caspase-3, and cleaved PARP1 in total cell lysate (TCL) were measured by ImageJ (version 1.4.5q) and are indicated as italic numbers. Data
shown are from two independent experiments. Po0.01
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(Figure 3b). siRNA-mediated BCLAF1 knockdown
(Supplementary Figure 4) also led to similarly increased
expression of p53 and p21 but slightly decreased cyclin E in
the IR-responsive cells. However, in the same type of A549
cells under IR-resistant condition, siRNA depletion of
BCLAF1 correlated with suppressed expression for p53,
p21, and cyclin E. Also, compared with IR-responsive cells,
the level of cyclin E, which was generally decreased with
siRNA knockdown of BCLAF1, showed an increase in the IR-
resistant A549 cells having already suppressed BCLAF1
(Figure 3b). Interestingly, in p53-deficient H1299 cells, both
activated p21 and reduced cyclin E were accompanied with
reduced BCLAF1 either under IR-resistant condition or
siRNA BCLAF1 knockdown (Figure 3b), collectively indicat-
ing that in a p53-independent but p21-dependent manner,
BCLAF1 differentially regulates the cyclin E-mediated path-
ways at G1/S phase based on the IR-responsive or -resistant
nature of the cells.
BCLAF1 negatively regulates the p21-dependent cell
cycle arrest in a H2AX-dependent manner. Next, we
investigated exactly how BCLAF1 affects the p21-dependent
cell cycle in the differentially irradiated cells. First, 82% of the
IR-responsive cells with BCLAF1 knockdown, and 91 or 70%
of IR-resistant cells without or with BCLAF1 knockdown were
retained in G1, compared with 60% G1 retention observed for
non-irradiated or other types of irradiated cells (Figure 3c).
This pronounced G1 retention associated with either siRNA-
mediated knockdown or IR-resistant downregulation of
BCLAF1 was concomitant with an increase of p21
(Figure 3b). Further, in the irradiated cells, BCLAF1 knock-
down led to an approximately two-fold increase of S-phase
cells coincident with a reduction of cyclin E, which is
generally downregulated in S phase (Figures 3b and c).
Also, in the immunofluorescence analysis of radiation effect
on the growth of wild-type A549 cells, we found that the high-
dose IR-induced chromatin condensation occurred only in
IR-responsive cells, indicating their pro-apoptotic nature
(Figure 3d and Supplementary Figure S5). In contrast, under
IR-resistant condition we found these cells not only formed
the multicellular spheroids characteristic of radio-resistance25
but also were accumulated more at G1 showing another
radio-resistant character26 (Figures 3c and d). Intriguingly, no
apparent condensed chromatin was observed in the
IR-responsive cells with BCLAF1 knockdown. Further, all
types of the cells with BCLAF1 knockdown became widely
distributed in a separate manner, and larger cell populations
were observed at S phase.26 This phenomenon of separated
distribution was more pronounced in the BCLAF1 knockdown
cells under IR-adapted conditions (Figures 3c and d). Taken
together, BCLAF1 is a negative regulator of p21-dependent
cell cycle arrest at either G1 or S phase and inhibits a pro-
survival-characteristic distribution of the cell population.
In addition to promoting cell cycle arrest, activated p21 was
also known to inhibit apoptosis by suppressing the activation
of Caspase 8 and pro-Caspase 3.27 We therefore investigated
whether BCLAF1 affects the activation of Caspase 8 and pro-
Caspase 3 by examining the p21 complexes immunoprecipi-
tated from differentially irradiated A549 cells without or
with BCLAF1 knockdown (Figure 3e). Stronger associations
between p21 and Caspase 8 or pro-Caspase 3 were observed
in either IR-resistant cells or the irradiated cells with BCLAF1
knockdown, indicating reduced levels of BCLAF1, either
naturally in radio-resistant cells or by siRNA, are required for
p21-mediated inhibition of Caspase-dependent apoptosis.
Further, in line with previous evidence that overexpression of
BCLAF1 induces a pro-apoptotic factor Bax,12 we found that
siRNA-mediated BCLAF1 knockdown led to suppressed Bax
expression, which was highly induced by a high-dose IR,
along with reduced activity of the Bax-downstream Caspase-9
and Caspase-3 as well as less cleaved PARP1 (a Caspase-3
substrate). These changes were more pronounced in IR-
responsive cells than in IR-resistant cells (Figure 3e). These
results collectively indicated that in IR-responsive cells,
BCLAF1 has a pronounced role in disrupting the p21-
dependent inhibition of activation of Caspase-dependent
mitochondrial-mediated apoptotic pathways.
BCLAF1 is a regulator in the gH2AX-mediated repair of
DNA DSBs. Based on our findings that BCLAF1 suppression
is associated with both the H2AX-mediated p21-dependent
cell cycle arrest and radio-resistance (Figure 3b), we
reasoned that depending on the IR-responsive versus -
resistant nature of the irradiated cells, BCLAF1 selectively
regulates both gH2AX-mediated DDR associated with either
apoptosis or DSB repair. We first investigated how BCLAF1
affects IR-induced formation of gH2AX foci, since such foci
quantitatively correlate with the extent of DNA damage.28 As
shown in Figure 4a, the IR-resistant cancer cells contained
much less DSB-indicative gH2AX and 53BP1 foci than those
in the 10-Gy-irradiated IR-responsive cells, indicating
attenuated DDR in tumor cells to repeated IR. BCLAF1
Figure 4 BCLAF1 regulates the subcellular-specific feedback loop in balancing apoptosis and cell cycle progression and DNA-PKcs regulates the formation of BCLAF1
foci. (a) Effect of BCLAF1 on the formation of DSB-indicative gH2AX and 53BP1 foci. A549 cells were harvested at 1 h after a defined IR and the percentage of gH2AX and
53BP1 foci-positive cells was determined by analyzing 100 randomly chosen cells and the number of gH2AX and 53BP1 foci per cell was determined on a cell-to-cell basis by
the quantitative analysis of at least 30 cells randomly chosen as previously described.32 Error bars represent S.D. of a technical duplicate. **Po0.05, *Po0.01.
(b) Immunoblot analysis of the effect of BCLAF1 on Ku70 associations with DNA-PKcs in differentially irradiated A549 cells. Relative intensities representing the binding
strength between DNA-PKcs and Ku70 measured by ImageJ (version 1.4.5q) are indicated as italic numbers. Data represent the average of two independent experiments.
Po0.05. (c) The Ku70 immunoprecipitates were isolated from cytosolic and nuclear fractions of non-irradiated, IR-responsive, -resistant cells by using an agarose-conjugated
Ku70 antibody. Individual complex components were immunoblotted with indicated antibodies. Relative intensities of interaction strength between DNA-PKcs, p18-cyclin E,
Bax and Bcl-2, and Ku70 measured by ImageJ (version 1.4.5q) are indicated as italic numbers and separately measured for either nuclear or Cytosolic fraction. Data are from
two independent experiments. Po0.01. (d) For each radiation condition without or with BCLAF1 knockdown, the cells were harvested after 1- or 8-h recovery time.
Quantitative measurements of gH2AX were performed as described in the Materials and Methods section. One experiment containing a technical duplicate representative of
two is shown with the data precision indicated by the error bar based on mean±S.D. of duplicate samples. **Po0.05, *Po0.01. (e) Immunostaining of IR-induced BCLAF1
foci in the DNA-PKcs wild-type (DNA-PKcsþ / ) and null (DNA-PKcs / ) MEF cells under either IR-responsive or -resistant condition. DAPI was used to stain DNA. More
than 200 cells from each condition were examined (scale bar is 8 mm)
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knockdown led to increased gH2AX and 53BP1 foci, surpris-
ingly, more dramatically in IR-resistant than in IR-responsive
cells. These results indicated that, first, BCLAF1 is actively
involved in repairing DSBs to reduce gH2AX and 53BP1 foci
in viable cells under IR-responsive condition. Second,
suppressed BCLAF1 was accompanied either by more IR-
resistant viable cancer cells with a larger population of
persistently unrepaired DSBs probably at S phase
(Figure 4a), or with deficient DNA repair,29 all emphasizing
that the central role of BCLAF1 in modulating diverse DDR,
the regulation of DSB repair in particular.
BCLAF1 positively regulates both formation of the DNA-
PK complex and the Ku70-mediated feedback loop. Our
proteomics data showed the DNA-PK complex enhanced
its interaction with gH2AX specifically in the 10-Gy-irradiated
IR-responsive cells, whereas non-detectable interaction
between gH2AX and ATM/ATR was found (Figure 1b and
Supplementary Table S1). Previous work indicated that the
formation of DNA-PK complex has a critical role in various
H2AX-mediated DSB repair processes,30 particularly through
non-homologous end joining (NHEJ) occurring at the G1/S
transition, where Ku70 is a key regulator.31 Further, BCL-2,
which interacts with BCLAF1 in vitro16 and negatively
regulates DSB repair by disruption of the Ku/DNA-PKcs
complex.32 Based on these established links, we first
examined whether BCLAF1 affects the integrity of this
DNA-PK complex. In Ku70 immunoprecipitates from differ-
entially irradiated cells, siRNA-mediated BCLAF1 knockdown
generally led to a weakened association between Ku70 and
DNA-PKcs, and to a greater extent in IR-resistant than in IR-
responsive cells (Figure 4b), indicating that BCLAF1 posi-
tively regulates Ku70/DNA-PKcs-coordinated DSB repair
through NHEJ.
Additionally, previous work indicated that Ku70 mediates a
feedback loop selectively modulating the propensity toward
apoptosis or cell cycle progression/survival.33 In this loop,
Caspase-3 activated by free Bax cleaves cyclin E to generate
an 18-kDa C-terminal fragment, p18-cyclin E, which then
complexes with cytosolic Ku70 to liberate the Ku70-bound
Bax for inducing mitochondria-mediated apoptosis.33,34
Based on our newly established links between BCLAF1 and
major loop components, including Ku70, cyclin E, Bax, and
Caspase-3 (Figures 3b and e), we then explored the function
of BCLAF1 in this Ku70-mediated feedback loop by compar-
ing the effect of BCLAF1 in formation of the Ku70 complexes
under different radiation conditions. Because both cyclin E
and DNA-PKcs are mainly localized in the nucleus, whereas
Caspase-3 and Bax function in the cytoplasm,30 our investi-
gation was conducted with subcellular resolution. In nuclei of
IR-responsive cells, BCLAF1 knockdown led to an increased
association between Ku70 and p18-cyclin E (Figure 4c),
indicating BCLAF1 may negatively regulate the DNA repair
process mediated by the nuclear Ku70/p18-cyclin E com-
plex,33 promoting apoptosis. On the other hand, in the cytosol
of BCLAF1-knockdown cells, Ku70 enhanced its binding to
Bax but weakened its interaction with p18-cyclin E, sug-
gesting that BCLAF1 is required to release Bax from the
anti-apoptotic Ku70–Bax complex in high-dose-irradiated
IR-responsive cells. Under IR-resistant condition, cytosolic
Ku70 formed a strong complex with Bax but weakened its
interaction with p18-cyclin E, while BCLAF1 knockdown affected
Ku70 binding to both proteins in a trend similar to wild-type cells
(Figure 4c), indicating inhibition of apoptosis in the IR-resistant
cancer cells is caused by the naturally suppressed BCLAF1.
Further, BCLAF1 knockdown had little effect on the stability of
the Ku70/p18-cyclin E complex in nuclei, suggesting a less
active status of Ku-mediated DNA repair with already reduced
BCLAF1. Coincidently, in the nuclear Ku70 complexes, BCL-2,
showed similar changes in its affinity to Ku70 as to p18-Cyclin E
(Figure 4c), indicating that, under IR-resistant condition with
suppressed BCLAF1, p18-Cyclin E may cooperate with nuclear
BCL-2 to suppress the NHEJ pathway for DNA repair.
Downregulation of endogenous BCLAF1 is associated
with suppressed activity of NHEJ repair. Further, com-
pared with 10-Gy-irradiated cells with a 1-h recovery, an
approximately 50% reduction of gH2AX was observed in the
IR-responsive cells recovered for 8 h, indicating activated
DSB repair under IR-responsive condition (Figure 4d).
However, less than 30% gH2AX reduction was found in
similar IR-responsive cells with BCLAF1 knockdown. Under
IR-resistant condition, neither a longer recovery time nor
BCLAF1 knockdown had any impact on the amount of
IR-induced gH2AX, probably due to already suppressed
BCLAF1, all collectively confirming the regulatory role of
BCLAF1 in NHEJ DNA repair.
DNA-PKcs regulates the formation/translocation of
BCLAF1 foci. As DNA-PKcs phosphorylate many sub-
strates involved in NHEJ-based DNA repair,35 we investi-
gated whether BCLAF1’s DNA repair function could also
depend on DNA-PKcs. In 10-Gy-irradiated DNA-PKcsþ /
MEF cells, a large number of the IR-induced BCLAF1 foci
were found widely distributed in nuclei, including some foci at
the nuclear envelope, while few BCLAF1 foci were observed
in the nucleoplasm of the 10-Gy-irradiated DNA-PKcs /
MEFs (Figure 4e). In contrast, in both DNA-PKcsþ / and
DNA-PKcs / MEFs under IR-resistant condition, the
numbers of nuclear BCLAF1 foci were all reduced compared
with those in IR-responsive cells (Figure 4e). Clearly, IR
induction of BCLAF1 foci requires both DNA-PKcs and
cellular sensitivity to radiation. Further, through tandem mass
spectrometry experiments, a predominant phosphoserine at
151 with a phosphotyrosine at 150 were unambiguously
identified at BCLAF1 isolated from 10-Gy-irradiated
DNA-PKcsþ / or DNA-PKcs / MEFs (Supplementary
Figure 6). However, compared with that originated from
irradiated DNA-PKcs /cells, the phosphorylation level of
serine 151 at BCLAF1 isolated from wild-type DNA-PKcsþ /
MEFs showed an approximately 30% increase in site
occupancy determined by our newly developed label-free
quantitation method using peak area and spectral counting
(Supplementary Figures 7 and 8). Given that serine 151 is
located in an RS domain, and such domains are known to
regulate subcellular localization36 (Supplementary Table S4),
these quantitative MS results suggested that, stimulated by
high-dose IR, DNA-PKcs drives BCLAF1 to the nuclear
envelope by directly phosphorylating key BCLAF1 RS resi-
due(s). Based on our observations that gH2AX could be
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co-localized with not only BCLAF1 (Figure 1d) but also
activated DNA-PKcs in the nuclei of 10-Gy-irradiated
IR-responsive cells, BCLAF1 may also co-localize with DNA-
PKcs at the same nuclear location, defining it as a DNA-PK-
dependent NHEJ repair protein.
Discussion
Although growing numbers of H2AX interactors involving
diverse biological processes have been identified, for cells
showing different sensitivities to radiation, it is still incomplete
as to how exactly H2AX coordinates specific pathways for
different cell fates and what co-factors are involved in these
pathways. Strategically, not starting with pre-conceived
notions, we first conducted a phenotype-specific dissection
of IR-induced H2AX-interacting protein network and then
performed zoom-in characterization of novel H2AX partners,
their H2AX-coordinated interplay on a pathway scale in
particular. Technically, by integrating the results from multiple
approaches of quantitative proteomics, cell biology,
immunoblotting and confocal imaging, we revealed a mechan-
istic view that in diverse gH2AX-dependent cell fate-determin-
ing pathways, an IR-inducible H2AX-associating partner,
BCLAF1, has diverse roles in regulating either apoptosis, or
cell survival with active DNA repair or carcinogenesis
(Figure 5).
Given that depletion of Bcl-2 could enhance the DNA-
binding activity of the Ku70/DNA-PKcs complex for accel-
erating DNA repair,32 our finding that BCLAF1 knockdown
causes a reduced association between Ku70 and DNA-PKcs
(Figure 4b) implied that BCLAF1 is required for stability of the
DNA-PK complex critical for NHEJ DSB repair. Mechanisti-
cally, in the gH2AX interactome induced by a high-dose acute
IR, DNA-PKcs is activated to phosphorylate both H2AX and
BCLAF1 resulting in the translocation of some BCLAF1 to
gH2AX foci in nuclei, where BCLAF1 serves as an inducer for
a p53-dependent G2/M arrest of irreparable cells as well as a
positive regulator of DNA-PK-dependent DNA repair in the
surviving cells with DSBs (Figure 5). Meanwhile, the remain-
ing BCLAF1 in cytosol is required for the pro-apoptotic side of
Figure 5 A mechanistic model illustrating the multiple roles of BCLAF1 in regulation of apoptosis, cell cycle progression, and NHEJ DBS repair. In IR-responsive cells
exposed to a high-dose radiation that activates DNA-PKcs, BCLAF1 re-localizes to the nuclear envelope through site-specific phosphorylation by DNA-PKcs and then
emerges with gH2AX foci, which in turn stabilizes the Ku70/DNA-PKcs complex for facilitating NHEJ DSB repair. Meanwhile, BCLAF1 regulates both cyclin E and p53/p21-
dependent mitochondria-mediated pathway(s) for promoting pro-apoptotic activity of Caspase-3, leading to the generation of an apoptotic amplifier, p18-cyclin E, followed by
Ku70-mediated liberation of active Bax. In contrast, in the IR-resistant carcinoma cells BCLAF1 is intrinsically suppressed, leading to weakened Ku70/DNA-PKcs complex but
enhanced associations of Ku70/BCL-2/p18-Cyclin E instead, subsequently reducing the activity of DSB repair. In the cytosol, suppressed BCLAF1 could result in more Ku70-
bound Bax, which inhibits the formation of pro-apoptotic Ku70-p18-Cyclin E complex
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Ku70-mediated feedback loop where BCLAF1 promotes
Caspase-3-mediated cleavage of cyclin E, and subsequently
induces the dissociation of Bax from its complex with Ku70 for
the activation of pro-apoptotic Bax.
On the other hand, BCLAF1 was found intrinsically
suppressed in tumor cells with natural radio-resistance.
Similar to the effects of siRNA-mediated BCLAF1 knockdown,
the suppressed BCLAF1 corresponds to less-translocated
BCLAF1 in nuclei, affecting the stability of the Ku70/DNA-
PKcs complex for reduced DNA repair, leading to p21-
dependent cell arrest at G1 phase or reentry to S phase with
replicating the errors caused by DSBs. Meanwhile, with less
BCLAF1 modulation, the Ku70-mediated Caspase-depen-
dent mitochondrial-mediated apoptotic pathways could be
inhibited for developing apoptosis resistance in mis-replicated
surviving cells, eventually leading to carcinogenesis. We
therefore concluded that BCLAF1 is a gH2AX-dependent
tumor suppressor.
On a systems view, our combined results reveals that cell fate
decision is made by the gH2AX-coordinated network specifically
involving BCLAF1 and DNA-PKcs, illustrating how the balance
between tissue protection from repetitive challenges and
eliminating irreparable DSBs could be tightly regulated, or
altered, or abrogated based on the extent of DNA damage.
Materials and Methods
Cell lines, reagents, and AACT/SILAC labeling. Human embryonic
kidney (HEK) 293T, normal human fibroblast strains (MRC-5 and WI-38), human
osteosarcoma strain (U-2 OS), human lung adenocarcinoma cell line A549, and
p53-deficient lung carcinoma H1299 cells were purchased from ATCC (Manassas,
VA, USA) and DNA-PKcs wild-type (DNA-PKcsþ / ) and null (DNA-PKcs / )
MEF cells were kindly provided by Dr. David J Chen. A 293T cell line stably
expressing FLAG-tagged H2AX (FLAG-H2AX) was established as described
previously.7 293T, DNA-PKcsþ / and DNA-PKcs / MEF cells, A549 and
H1299 cells were maintained in D-MEM supplemented with 10% FBS, 1%
penicillin and streptomycin, U-2 OS cells were grown in McCoy’s 5a with 10%
FBS, 1% penicillin, and streptomycin, and MRC-5 and WI-38 cells were in MEM
with 10% FBS, 1% penicillin, and streptomycin, 0.1 mM NEAA and 1 mM sodium
pyruvate (Invitrogen, Carlsbad, CA, USA). For AACT labeling, the FLAG-H2AX
cells were grown in media supplemented with either L-12C6-arginine (‘light’), or
L-13C6-arginine (‘medium’), or L-
13C6,
15N4-Arginine (‘heavy’) (Cambridge Isotope
Laboratories, Andover, MA, USA), respectively. siRNA duplexes targeting BCLAF1
were synthesized and purified by Sigma (St. Louis, MO, USA) (MISSION siRNA)
and transfected with Lipofectamine RNAiMAX (Invitrogen). The following
siRNA sequences were used: BCLAF1 #1, 50-CAAGAAUUCCGAUCCAUCU-30;
#2, 50-AGAUGGAUCGGAAUUCUUG-30.
Radiation treatment and H2AX immunoprecipitation. Stable cells
incorporating 13C6-Arg or
13C6
15N4-Arg tags were exposed to a g-ray (AECL
Gammacell 40 Irradiator) at 7.5 cGy or 10 Gy, respectively, at the dose rate of 0.75
Gy min 1 followed by 1 h recovery. Approximately 8 108 cells of each type were
harvested and H2AX complexes were immunoprecipitated as previously
described.7
Mass spectrometry. IP elutes were separated on NuPAGE 4–12% bis-tris
gel (Invitrogen). After staining with Coomassie Brilliant Blue, the entire gel lane
was cut into contiguous 22 slices. In-gel digestion was performed on each gel slice
and the mixture of peptide digests was extracted from gel. For LC-MS/MS
analysis, each peptide set was desalted using the house-made C18 STAGE tips,
37
and then separated with on-line Eksigent nanoLC system coupled to an LTQ-
Orbitrap hybrid mass spectrometer (Thermo Electron, San Jose, CA, USA) which
is equipped with a nano-electrospray source (New Objective, Inc., Woburn, MA,
USA). The peptides were first loaded on IntegraFrit trapping column (ProteoPep II
C18, 300 Å, 5 mm, 100mm 25 mm, New Objective, Inc.) by using mobile phase
of 5% acetonitrile (ACN) in 0.1% formic acid (FA). The retained peptides were
washed with the same buffer and were separated on a PicoFrit Analytical Columns
(ProteoPep II C18, 300 Å, 5mm, 50mm 100 mm, tip ID¼ 10mm, New Objective,
Inc.) by applying a multistep gradient of ACN (5% A in 5 min, 5–40% A in 40 min,
40-90% A in 70 min, isocratic gradient 5 min at 90%, 90-5% A in 95 min; solvent A:
0.1% FA; solvent B: 0.1% FA in 95% ACN). The set of MS/MS raw data first
converted to DTA files using ThermoElectron Bioworks 3.3.1 was searched
against the IPI-human Fasta database using SEQUEST. The parameters for data
search included (1) variable modifications allowing mass difference of 80 Da
for possible phophorylation and 6, or 10 Da for 13C6-Arg, or
13C6,
15N4-Arg,
respectively, (2) tryptic peptides with allowance of two missed cleavages, and (3)
top hit(s) with individual cross-correlation over the threshold dependent on
precursor charge states. The proteins with at least two peptides detected
(Po0.05) were considered as positive identifications. PepQuan software was
used for AACT/SILAC-based peptide/protein quantification.
AACT-based quantitation for distinguishing dose-dependent
H2AX interactors. For each arginine-containing peptide, a set of three
isotope signals spacing by 6 Da and 10 Da were observed as the ‘light (L)’ isotope
peak was originally from the non-irradiated cells, and the 6 Da (M) or 10 Da (H)
signals came from the cells irradiated by IR at 7.5 cGy or 10 Gy, respectively. The
ratio of any paired heavy versus light isotope signals, that is, M/L or H/L, was then
correlated with the IR-induced dose-dependent abundance of individual protein
bound to H2AX (bait) (Figure 1b). With respect to the relative abundance of H2AX in
the immunoprecipitate mixture, which was found to be equal at 1 : 1 : 1, we have set
a quantitative threshold to distinguish those IR-inducible/induced H2AX-interacting
partners from non-specific background. In reference to the criteria previously
established by our group,38 we first found the average relative S.D. (RSD) for
quantitative measurements of M/L or H/L ratio was at 8.9% and then used three-fold
RSD, which was approximately equal to 30% changes in the H2AX-bound
abundances as the threshold. For most of non-specific contaminants, their M/L or H/
L ratios were close to a unity because of their possibly equal distribution in each
immunoprecipitate, for example, hnRNPA1, any identified protein with H/L larger
than 1.3 or less than 0.7 was indicative of that its association with H2AX was
enhanced or weakened upon the radiation at defined dose level.
Label-free quantitation. Label-free quantitation was performed using MS1
peak area as described previously,39 and total protein quantitation based on MS2
spectral counting was performed via ProteoIQ label-free quantitation software
(NuSep, Bogart, GA, USA).
Bioinformatics analysis. PANTHER (http://www.pantherdb.org) and
DAVID (http://david.abcc.ncifcrf.gov/) were used to analyze the functional category
of the identified proteins. Domain analysis was performed by using similar
hierarchical clustering approach13 with modifications: both interaction and functional
domains in each H2AX-binding protein were identified by SMART (Simple Modular
Architecture Research Tool) and Pfam (Protein Family Database). A statistical
algorithm based on the average-linkage method was used to establish a similarity
metric that relates proteins based on the correlation coefficient of their domains, and
vice versa. The cluster file was loaded onto Treeview (version 1.60; http://
rana.lbl.gov/EisenSoftware.htm) to generate a 2D branched-tree image including the
phylogenic order of proteins and domain entries.
Co-immunoprecipitation and immunoblotting. Nuclear extracts and
immunoprecipitates were obtained, separated, and transferred as described
previously,7 The PVDF membranes (Bio-Rad, Hercules, CA, USA) were blotted
respectively with a rabbit polyclonal antibody against BCLAF1 (A300-608A,
BETHYL laboratories, Inc., Montgomery, TX, USA), and Histone H3S10ph
(ab47297, Abcam, Cambridge, MA, USA), and DNA-PKcs (4602), cleaved
Caspase-3 (Asp175) (9664), Caspase 8 (4927) and Bax (2772) (Cell Signaling
Technology, Danvers, MA, USA) and Cyclin D1 (H-295) (sc-753) (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA); goat-polyclonal antibody against
b-actin (sc-1615) (Santa Cruz Biotechnology, Inc.) and GAPDH (IMG-3073)
(Imgenex Inc., San Diego, CA, USA); mouse monoclonal antibody against FLAG
M2 (F1804), BrdU (B8434) and p21 (P1484) (Sigma), gH2AX (ab22551) (Abcam)
and, PARP1 (sc-8007), p53 (DO-1) (sc-126), Bcl-2 (C-2) (sc-7382) and Ku70
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(N3H10) (sc-56129) (Santa Cruz Biotechnology, Inc.) and Caspase-9 (9508) (Cell
Signaling Technology) and Cyclin E (Ab-2) (MS-870-P0) (Thermo Scientific, Inc.,
Waltham, MA, USA) and 53BP1 (612522) (BD, San Jose, CA, USA). The
membranes were incubated with anti-rabbit (Thermo Scientific), anti-mouse (Bio-
Rad) or anti-goat (Invitrogen) immunoglobulin G-peroxidase conjugate and
visualized by using an ‘ECL plus’ detection kit (GE Healthcare, Waukesha, WI,
USA). The levels of Cyclins D1 and E and gH2AX proteins from immunoblotting
assays were quantified by densitometry with ImageJ software.
Immunofluorescence assay. Cells were grown on coverslips, irradiated,
washed with PBS, fixed with 4% formaldehyde, and permeabilized with 0.1%
NP-40 for 5 min at room temperature. The cells were then incubated in blocking
buffer (PBS containing 3% BSA) for 30 min, followed by incubation with the
primary antibody (anti-gH2AX antibody or anti-53BP1 antibody or anti-BCLAF1
antibody for co-localization assay; anti-BrdU or anti-Histone H3S10ph for cell cycle
assay), and blocking with 1% BSA in PBS for 1 h. Following PBS washing, the
cells were incubated with secondary antibody (Alexa-488-conjugated anti-mouse
IgG or Alexa-568-conjugated anti-rabbit IgG (Molecular Probes, Life Technologies,
Grand Island, NY, USA) for 1 h. Following a wash with PBS-containing 4,6-
diamidino-2-phenylindole (DAPI; Invitrogen), coverslips were mounted onto glass
slides using Permount solution (Fisher Scientific, Pittsburgh, PA, USA). Confocal
laser scanning microscopy was performed on a LeicaSP2 AOBS Upright laser
scanning confocal microscope using the 354-nm line of a UV laser and the 488-
and 568-nm lines of argon and helium-neon lasers. The images were processed
using LCS Lite software (Leica, Buffalo Grove, IL, USA).
Semi-quantitative RT-PCR analysis. Total RNA (approximately 2mg)
was isolated by using RNeasy spin column kits (Qiagen, Valencia, CA, USA), and
then reverse transcribed into cDNA by using Superscript II reverse-transcriptase
(Invitrogen) at 50oC. Control reactions were performed without template RNA and
Superscript II or with no template cDNA. PCR reactions were done with the cDNA
generated from 500 ng of total RNA in a 25-ml reaction, in triplicate for each
sample. Both p53 and b-actin were amplified by described primer sets.40
Chromatin immunoprecipitation (ChIP) assay. IR-treated cells were
cross-linked at 80% to 90% confluence with 1% formaldehyde, incubated for
15 minutes and then quenched with 0.1 M glycine-PBS for 5 minutes. The
collected cells were washed with 50 mM glycine-PBS and harvested. Each ChIP
was performed using SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling). In
all, 2% of the cellular extract before immunoprecipitation was used for the input
control. DNA was purified by DNA Purification Columns (Cell Signaling). PCR
amplification was performed in ChIP fragments using the oligonucleotide
sequences described previously.11
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